ߜ This report presents two cases of hypervascular tumor in which the cavernous and petrous internal carotid artery feeding vessels were successfully occluded using a new endovascular device, the crescent-shaped platinum Guglielmi detachable coil (GDC). With this new embolic agent the risk of unwanted embolization of normal intracranial arteries was significantly reduced. The GDC "crescent" seems particularly useful when distal, superselective, and controllable occlusion of small arterial feeding vessels is the goal of the treatment.
XTRADURAL and cavernous branches of the internal carotid artery (ICA) may contribute to the vascular supply of some tumors. In particular, petrous ICA branches may form part of this supply in hypervascular tumors such as chemodectomas and juvenile angiofibromas, whereas neoplasms that involve the tentorium, cavernous sinus, or clivus are often fed by cavernous branches of the ICA. 1, 6 Presurgical devascularization of these tumors seems to be particularly valuable, although not easily accomplished. 8 In fact, because of their small size, cavernous and petrous branches of the ICA are traditionally arduous or impossible to catheterize, even with smaller microcatheters. Furthermore, even if catheterization is successful, the microcatheter may not be stable enough to allow safe delivery of embolic agents without the risk of reflux into the main stream of the ICA. This report presents a new endovascular device that was used to devascularize the cavernous and petrous ICA supply to hypervascular tumors, with a significantly reduced risk of unwanted embolization of normal distal ICA vessels.
Description of the Embolic Device
The overall physical structure of the embolic device is similar to that of the Guglielmi detachable coil ([GDC]; Target Therapeutics, Fremont, CA), which is an electrolytically detachable platinum coil that is used to treat brain aneurysms. 3, 4 Unlike the GDCs used for aneurysms, which are formed by many centimeters of helical platinum coil, this version of the GDC is short and slightly curved (Fig.  1) . The crescent-shaped, detachable occlusive platinum coil is soldered to the distal end of a delivery wire. The coil can be 4 or 6 mm in length and 0.010 or 0.018 in (0.25 or 0.45 mm) in diameter. The stainless steel delivery wire has a 0.010-in diameter and is 175 cm long. Its distal 0.5-mm portion is uninsulated to allow electrolytic breakdown with consequent detachment of the platinum coil ( Figs. 1  and 2 ). The crescent shape of the coil allows it to be steered by torquing the delivery wire. The coil is maneuverable and can be guided into the targeted vessel beyond the tip of the microcatheter. The device can also be re-trieved and/or repositioned at will. Once the selected placement is achieved, the coil is detached from the delivery wire. This is accomplished by applying a 1-mA positive direct electrical current to the proximal, uninsulated end of the delivery wire. A subcutaneous needle constitutes the grounded negative electrode. Besides initiating detachment, the positive current induces the formation of an endovascular "electrothrombus." 4, 7 The smaller-sized coils (0.010 in) are used for occlusion of smaller vessels (≤ 0.4 mm), whereas the larger coils (0.018 in) are used for vessels larger than 4 mm.
The GDC crescent has already been used in seven cases in which distal and controllable occlusion of small arterial branches was needed. Of these seven patients, three had arteriovenous malformations fed by the anterior choroidal artery (unpublished data), two had peripheral intracranial aneurysms, 2 and a dural fistula of the cavernous sinus 9 and an arteriovenous fistula of the spinal cord were present in one each (unpublished data).
In this report two additional cases are described in which the GDC crescent was used as the embolic agent in hypervascular tumors.
Illustrative Cases

Case 1
This 60-year-old man presented with clinical evidence of a right-sided sphenopetroclival meningioma, which was diagnosed based on computerized tomography and magnetic resonance studies. It was decided to perform a preoperative embolization of the tumor. Transfemoral angiographic studies demonstrated that the tumor was mainly fed by intracavernous branches of the right ICA, with only a minor supply from both external carotid artery (ECA) systems. It was possible to position the tip of a Tracker 10 microcatheter at the ostium of the lateral clival artery. Because the catheter was in an unstable position and the artery was too small to be catheterized, it was concluded that with any embolic agent there would be a risk of reflux into the ICA, with possible embolization of normal intracranial vasculature. Therefore, a total of four GDC crescents were delivered and detached in the proximal portion of the clival arteries, thus eliminating the ICA blood supply to the tumor (Fig. 3) . Predetachment angiograms were obtained to assess proper coil placement and to avoid deposit in the ICA. This eliminated the risk of unwanted positioning of the coils in the normal vasculature. The patient underwent successful surgery 2 days after the endovascular procedure.
Case 2
This 23-year-old man presented with clinical evidence of a right-sided juvenile angiofibroma, which was diagnosed based on computerized tomography and magnetic resonance studies. Transfemoral angiographic studies demonstrated that the tumor was fed mainly by ECA branches. However, approximately 20% of the blood supply was provided by an intrapetrous ICA branch: the vidian artery. The ostium of this artery was identified and a Tracker 10 microcatheter was positioned there. Because of its small size, catheterization of the vessel was not possible. With the microcatheter in this unstable position it was decided to use the GDC crescent to occlude the artery. In fact, it was believed that with any other embolic agent there would have been a risk of reflux into the ICA with possible unwanted occlusion of normal intracranial arteries. A single GDC crescent was sufficient to occlude the vidian artery (Fig. 4) . Subsequently, the tumor was embolized via the ECA feeding vessels. The patient underwent a successful operation the day after the endovascular treatment.
Discussion
The extradural and intracavernous ICA gives rise to very small branches that, under normal conditions, are not visible on angiograms. The intrapetrous ICA gives rise to the caroticotympanic artery, which supplies the middle and inner ear, and the vidian artery (or artery of the pterygoid canal), which, after an anterior course through the foramen lacerum and vidian canal, communicates with ECA branches. 6 These two arteries may enlarge when supplying hypervascular tumors such as glomus tumors and juvenile angiofibromas, respectively.
The cavernous ICA gives rise to the meningohypophy- seal artery that supplies the tentorium (marginal tentorial branch or artery of Bernasconi and Cassinari), dura of the cavernous sinus, dura of the clivus, and the posterior pituitary gland (inferior hypophyseal artery); and the inferolateral trunk, which supplies the cavernous sinus dura and the third through sixth cranial nerves. 6 Most of these branches may connect with branches of the ECA system and become enlarged to supply tumors of the tentorium, cavernous sinus, and clivus.
These hypervascular tumors may be fed by both systems and may have a mixed blood supply, with branches of the ECA also contributing to their vascular supply. Depending on the relative contribution of the two vascular systems (ICA-ECA) there are lesions that are fed mainly by ICA branches and others fed mainly by ECA branches, with both systems being in a hemodynamic balance. In general, in medially located tumors the ECA contribution is less prevalent than that of the ICA. Even if one of these two systems predominates over the other, elimination of the blood supply of one system may change the blood flow hemodynamics in such a manner that the remaining system begins to supply the entire lesion. 8 Elimination of the ICA contribution may therefore alter the hemodynamics in such a manner that the subsequent ECA embolization will involve the entire tumor mass, including portions previously fed by the ICA. Occluding the trunk of the feeding vessels arising from the ICA favors this redistribution of the blood flow. Furthermore, initial occlusion of the ICA feeding vessels may allow a safer subsequent ECA embolization by reducing the likelihood of injecting embolic agents into the main stream of the ICA, in a retrograde fashion, via these feeding vessels.
Endovascular embolization of these hypervascular tumors has been advocated to diminish or eliminate their
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Embolization using the GDC crescent blood supply. This may be accomplished preoperatively or as a palliative treatment. Preoperative embolization should be performed the day before surgery. It may decrease surgical morbidity by reducing blood loss, shortening operating time, reducing the risk of damage to surrounding structures, and increasing the chances of complete tumor resection. However, elimination of the ICA contribution to these hypervascular tumors is difficult to achieve.
Currently, embolization of small ICA branches can be achieved by performing a superselective microcatheterization of these small branches, followed by injection of liquid or particulate embolic agents. 8 However, often the microcatheter is not in a stable enough position to allow the surgeon to perform a safe embolization, and reflux of embolic agents into the main stream of the ICA is a major concern. As an alternative, a nondetachable balloon can be temporarily inflated in the ICA, occluding the artery just distal to the intracavernous branches. Particulate emboli are then injected into the ICA through a microcatheter positioned at the petrous or the proximal C-5 portion. 8 Prior to balloon deflation, multiple aspirations and rinsing of the ICA are necessary; after balloon deflation, despite these precautions, particles still lying in the stagnant ICA may occlude normal cerebral arteries. Functional embolization has been proposed as another alternative. 5 It consists of performing temporary balloon occlusion of the ICA across the origin of the supplying cavernous or petrous branches, thus changing the hemodynamics as described earlier and allowing embolization of the entire tumor via the ECA system. All these techniques involve the risk of unwanted embolization of normal intracranial arteries either because of the unstable position of the microcatheter or because the inflation of balloons in the ICA combined with the use of two systems may increase the rate of thromboembolic complications. Because of these limitations, often only ECA embolization is performed, leaving the ICA feeding vessels untouched.
With the embolic device described here it was possible to eliminate the ICA supply to hypervascular tumors in a safe and controllable manner. The GDC crescent can be positioned and repositioned at will, can be extended beyond the tip of the microcatheter in a controlled fashion, and can then be detached without the risk of dislodging it and without exerting mechanical force.
